Charles Mullighan Has Been Elected as a Fellow of The Royal Society of London – St. Jude Children’s Research Hospital
St. Jude Children’s Research Hospital posted on LinkedIn:
“Charles Mullighan senior deputy director of the St. Jude Comprehensive Cancer Center, has been elected as a Fellow of The Royal Society of London, the world’s oldest scientific academy in continuous existence.
Mullighan is recognized for his groundbreaking contributions to genomic research, which have transformed the understanding, diagnosis and treatment of acute leukemia, particularly childhood acute lymphoblastic leukemia (ALL). His work has redefined the disease by identifying novel subtypes, uncovering key genomic drivers and advancing precision medicine approaches.
“I am deeply honored by this recognition of our contribution to cancer research and grateful to the many researchers and mentors who have contributed to this work. The advances we have made were only possible due to the substantial support for research and collaborative environment at St. Jude.” Mullighan said.
“The Royal Society and St. Jude share a belief that science should benefit humanity, and that’s exactly why Dr. Mullighan so richly deserves this recognition. Since he joined St. Jude more than 20 years ago, Dr. Mullighan’s quest to advance the understanding and treatment of childhood leukemia has saved and improved the lives of countless children around the world.” – said James R. Downing, MD, president and CEO of St. Jude.
We celebrate this remarkable achievement and the impact his work continues to have on improving outcomes for children with leukemia worldwide. Congratulations, Dr. Mullighan!
More posts featuring St. Jude Children’s Research Hospital.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023